LBO — ST. JOSEPH MEDICAL CENTER
IRR: 20.7% | MOIC: 2.56x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
20.7%
IRR
2.56x
MOIC
$132.7M
Entry EV
$234.1M
Exit EV
$68.3M
Equity Invested
Sources & Uses
S&UTotal · $132.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $51.5M | 38.8% | |
| Sub Debt | $12.9M | 9.7% | |
| Equity | $68.3M | 51.5% | |
| Enterprise Value | $128.9M | 97.1% | |
| Transaction Fees | $3.9M | 2.9% | |
| Total Uses | $132.7M | 100.0% |
Interpretation
INTAt 2.56x MOIC and 20.7% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $22.3M |
| Exit Ev | $234.1M |
| Net Debt At Exit | $59.1M |
| Equity At Exit | $175.0M |
| Equity Invested | $68.3M |
| Total Value Created | $106.7M |
| Value From Growth | $98.8M |
| Value From Multiple | $6.4M |
| Value From Deleveraging | $5.3M |